GelStat Corp. (GSAC)
OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
Sep 15, 2025, 8:00 PM EDT
GelStat Market Cap
GelStat has a market cap or net worth of $1.50 million as of September 17, 2025. Its market cap has increased by 175.56% in one year.
Market Cap
1.50M
Enterprise Value
2.15M
Revenue
349.73K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 19, 2003, GelStat's market cap has decreased from 7.47M to 1.50M, a decrease of -79.97%. That is a compound annual growth rate of -7.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 1.50M | 66.77% |
| Dec 31, 2024 | 897.13K | 65.23% |
| Dec 29, 2023 | 542.96K | -7.72% |
| Dec 30, 2022 | 588.36K | -89.93% |
| Dec 31, 2021 | 5.84M | 199.52% |
| Dec 31, 2020 | 1.95M | 160.00% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Tian'an Technology Group | 792.01M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| CytoDyn | 377.06M |
| Northwest Biotherapeutics | 373.88M |
| American Oncology Network | 345.48M |